Skip to content

Supplier News

Coca-Cola, Lady Liberty mark 125th anniversaries

Marking the 125th anniversary of "two American icons," the Coca-Cola Foundation donated $1 million to support The Statue of Liberty-Ellis Island Foundation’s Peopling of America Center, a new initiative that will tell the story of the immigration experience in America.

More N.Y. drug stores carry Identigene DNA paternity test

Identigene has expanded retail distribution of its DNA Paternity Test Kit in New York to drug stores throughout the state. The company said Tuesday that the Identigene DNA Paternity Test Kit is now available more than 1,600 chain drug stores and independent pharmacies in New York.

Akorn to form new unit with AVR acquisition

Niche generic pharmaceutical maker Akorn Inc. aims to extend its reach into the consumer eye care space with its $26 million cash deal to buy Advanced Vision Research (AVR) Inc. Akorn said that with the acquisition, it plans to launch a new consumer health division to enter the $1.

Catalina Marketing CEO Buell departs

Dick Buell, chairman and chief executive officer of Catalina Marketing Corp., is leaving the company. The shopper and patient marketing and research firm said Monday that George Off, Catalina’s co-founder and former CEO, has been named interim chief executive by the company’s board of directors.

Boehringer Ingelheim supports colon cancer event

Boehringer Ingelheim helped the Colon Cancer Alliance in its effort to raise public awareness of colon cancer with its sponsorship of the third annual Undy 5000 five-kilometer run in St. Louis. The event was the third of a dozen Undy 5000s that will be held nationwide this year.

Galderma launches Tactuo acne topical in Canada

Galderma has rolled out Tactuo, its prescription topical acne gel, to pharmacies in Canada. Galderma Canada Inc. said Monday that Tactuo, marketed under the name Epiduo in most countries, is the No. 1 prescribed topical acne medication in the United States.

Percodan generic released by Mylan

Mylan Inc. has launched oxycodone and aspirin tablets, a treatment for moderate to severe pain. The company said Thursday that the product, oxycodone and Aspirin Tablets 4.8355 mg/325 mg, were launched by its Mylan Pharmaceuticals Inc.